Today

Agents

Chat

Arena

Discover

More

App

TransCode Therapeutics Appoints John Tattory As Interim CFO - RNAZ News | Rallies

TransCode Therapeutics Appoints John Tattory As Interim CFO

RNAZ•2026-09-10

Leadership transition

Sept. 10 (Reuters) - Transcode Therapeutics Inc RNAZ.O:

Transcode Therapeutics announces leadership transition
Transcode Therapeutics - Tom Fitzgerald announces retirement as chief financial officer
Transcode Therapeutics - appoints John Tattory as interim chief financial officer effective immediately

Related News

Amkor CFO Megan Faust sells 1,000 common shares for $49,050

AMKR•2026-09-10

Vulcan Infrastructure and Power closes USD 39.4 million private placement at USD 1.71 a share

VIP•2026-09-10

BlackRock Enhanced International Dividend Trust portfolio manager Wendy G. Agnew files initial beneficial ownership statement

BGY•2026-09-10

Dell Technologies launches $5 billion senior notes offering

DELL•2026-09-10

Warner Bros Discovery Chief People & Culture Officer Amy Girdwood sells 262,285 shares for $7.34 million

WBD•2026-09-10